Sequoia Financial Advisors LLC Buys 4,156 Shares of Agilent Technologies, Inc. $A

Sequoia Financial Advisors LLC boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 10.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,568 shares of the medical research company’s stock after purchasing an additional 4,156 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Agilent Technologies were worth $5,464,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Norges Bank acquired a new position in Agilent Technologies during the second quarter worth $395,088,000. AQR Capital Management LLC increased its stake in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after buying an additional 1,652,244 shares during the period. Ameriprise Financial Inc. raised its holdings in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after acquiring an additional 1,273,994 shares during the last quarter. Finally, Troy Asset Management Ltd increased its holdings in Agilent Technologies by 74.3% in the second quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after purchasing an additional 1,021,865 shares during the last quarter.

Agilent Technologies Stock Down 3.6%

Shares of NYSE A opened at $139.68 on Tuesday. The company has a 50 day simple moving average of $144.27 and a 200 day simple moving average of $133.67. The firm has a market cap of $39.60 billion, a PE ratio of 30.56, a price-to-earnings-growth ratio of 4.05 and a beta of 1.29. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The company had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the prior year, the firm posted $1.46 earnings per share. The business’s quarterly revenue was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.25. The ex-dividend date of this dividend is Tuesday, January 6th. Agilent Technologies’s payout ratio is 22.32%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of the business’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total transaction of $130,491.64. Following the completion of the sale, the chief executive officer owned 32,058 shares in the company, valued at $4,591,987.92. This represents a 2.76% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 16,401 shares of company stock valued at $2,468,962.

Analysts Set New Price Targets

A has been the subject of several research analyst reports. Rothschild Redb upgraded Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. UBS Group upped their target price on Agilent Technologies from $170.00 to $180.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Finally, The Goldman Sachs Group began coverage on shares of Agilent Technologies in a research report on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $163.31.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.